Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
Tariq KewanTarini N GunaratneKomal MushtaqDina AlayanHamed DawAbdo HaddadPublished in: Transfusion (2021)
ITP secondary to COVID-19 usually presents after the first week of symptoms beginning. Most of our patients had WHO Grade 1-2 bleeding scores. Standard treatment with glucocorticoids and IVIG is effective in achieving an excellent response. The safety of eltrombopag is not very well established in COVID-19 patients, and additional studies are needed for a better safety profile.
Keyphrases
- sars cov
- coronavirus disease
- end stage renal disease
- ejection fraction
- newly diagnosed
- primary care
- prognostic factors
- atrial fibrillation
- randomized controlled trial
- peritoneal dialysis
- type diabetes
- respiratory syndrome coronavirus
- skeletal muscle
- depressive symptoms
- adipose tissue
- patient reported outcomes
- physical activity
- patient reported
- replacement therapy
- placebo controlled